No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk

European Journal of Gastroenterology & Hepatology
Elijah J MunG N Ioannou

Abstract

It is unclear whether there are differences between direct-acting antivirals (DAAs) for hepatitis C virus in risk of hepatocellular carcinoma (HCC) after antiviral therapy. We aimed to compare different DAA regimens with respect to risk of de novo HCC following antiviral therapy. We identified 33 137 patients who initiated hepatitis C virus antiviral treatment in the Veterans Affair healthcare system between 6 December 2013 and 31 December 2015 with one of four DAA-only regimens (± ribavirin): paritaprevir/ritonavir/ombitasvir/dasabuvir (n=6289), sofosbuvir (n=4356), sofosbuvir+simeprevir (n=3210), and ledipasvir/sofosbuvir (n=19 282). We retrospectively followed patients until 15 June 2017 to identify incident (de novo) cases of HCC. We used propensity score-adjusted Cox proportional hazards regression to compare different DAA regimens with respect to HCC risk. During a mean follow-up of 1.52 years, 741 new cases of HCC were diagnosed after antiviral treatment (annual incidence=1.47%). Patients treated with sofosbuvir+simeprevir had the highest annual HCC incidence (2.47%), followed by sofosbuvir (1.91%), ledipasvir/sofosbuvir (1.26%), and paritaprevir/ritonavir/ombitasvir/dasabuvir (0.95%). However, there were great differenc...Continue Reading

References

Jan 19, 2005·The American Journal of Gastroenterology·Jennifer R KramerHashem B El-Serag
May 19, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·George N IoannouSum P Lee
Jun 15, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lisa I BackusLarry A Mole
Aug 19, 2007·Journal of Clinical Gastroenterology·Jessica A DavilaHashem B El-Serag
Aug 10, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Lauren A BesteJason A Dominitz
Nov 11, 2010·The American Journal of Gastroenterology·Jennifer R KramerHashem B El-Serag
Apr 26, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·George N IoannouEdward J Boyko
Jun 9, 2012·Journal of Viral Hepatitis·F Poordad, D Dieterich
Oct 15, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eric M YoshidaEric Lawitz
Mar 8, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hashem B El-SeragJennifer Kramer
Jun 12, 2016·Journal of Hepatology·UNKNOWN ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CirVir and CO23 CUPILT cohorts). Electr
Oct 25, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Feng SuGeorge N Ioannou
Nov 5, 2016·Drug and Alcohol Dependence·Judith I TsuiGeorge N Ioannou
Apr 8, 2017·Seminars in Liver Disease·María ReigJordi Bruix
Jun 7, 2017·Journal of Viral Hepatitis·K JohnsonG N Ioannou
Jun 24, 2017·Gastroenterology·Fasiha KanwalHashem B El-Serag
Dec 6, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Darrick K LiAdeel A Butt

❮ Previous
Next ❯

Citations

Mar 23, 2021·Journal of Clinical and Experimental Hepatology·Ameer AbutalebEleanor Wilson
Nov 15, 2020·Revista de gastroenterología de México·R Tapia-SosaI García-Juárez
Oct 21, 2020·European Journal of Gastroenterology & Hepatology·Mohamed OmranHend Ibrahim Shousha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.